A two-step program preventing bone metastatic relapse

Authors: Bethany A. Kerr

Published: 2019-11-28

DOI: 10.1126/scitranslmed.aaz9759

Source: Full article


Abstract

Treating bone metastatic prostate cancer with docetaxel nanoparticles and denosumab averts tumor regrowth.